TY - JOUR
T1 - Molecular mechanism for the inhibition of DXO by adenosine 3′,5′-bisphosphate
AU - Yun, Ji Sook
AU - Yoon, Je Hyun
AU - Choi, Young Jun
AU - Son, Young Jin
AU - Kim, Sunghwan
AU - Tong, Liang
AU - Chang, Jeong Ho
N1 - Publisher Copyright:
© 2018 Elsevier Inc.
PY - 2018/9/26
Y1 - 2018/9/26
N2 - The decapping exoribonuclease DXO functions in pre-mRNA capping quality control, and shows multiple biochemical activities such as decapping, deNADding, pyrophosphohydrolase, and 5′-3′ exoribonuclease activities. Previous studies revealed the molecular mechanisms of DXO based on the structures in complexes with a product, substrate mimic, cap analogue, and 3′-NADP + . Despite several reports on the substrate-specific reaction mechanism, the inhibitory mechanism of DXO remains elusive. Here, we demonstrate that adenosine 3′ 5′-bisphosphate (pAp), a known inhibitor of the 5′-3′ exoribonuclease Xrn1, inhibits the nuclease activity of DXO based on the results of structural and biochemical experiments. We determined the crystal structure of the DXO–pAp-Mg 2+ complex at 1.8 Å resolution. In comparison with the DXO–RNA product complex, the position of pAp is well superimposed with the first nucleotide of the product RNA in the vicinity of two magnesium ions. Furthermore, biochemical assays showed that the inhibition by pAp is comparable between Xrn1 and DXO. Collectively, these structural and biochemical studies reveal that pAp inhibits the activities of DXO by occupying the active site to act as a competitive inhibitor.
AB - The decapping exoribonuclease DXO functions in pre-mRNA capping quality control, and shows multiple biochemical activities such as decapping, deNADding, pyrophosphohydrolase, and 5′-3′ exoribonuclease activities. Previous studies revealed the molecular mechanisms of DXO based on the structures in complexes with a product, substrate mimic, cap analogue, and 3′-NADP + . Despite several reports on the substrate-specific reaction mechanism, the inhibitory mechanism of DXO remains elusive. Here, we demonstrate that adenosine 3′ 5′-bisphosphate (pAp), a known inhibitor of the 5′-3′ exoribonuclease Xrn1, inhibits the nuclease activity of DXO based on the results of structural and biochemical experiments. We determined the crystal structure of the DXO–pAp-Mg 2+ complex at 1.8 Å resolution. In comparison with the DXO–RNA product complex, the position of pAp is well superimposed with the first nucleotide of the product RNA in the vicinity of two magnesium ions. Furthermore, biochemical assays showed that the inhibition by pAp is comparable between Xrn1 and DXO. Collectively, these structural and biochemical studies reveal that pAp inhibits the activities of DXO by occupying the active site to act as a competitive inhibitor.
KW - 5′-3′ exoribonuclease
KW - Adenosine 3′,5′-bisphosphate
KW - Crystal
KW - DXO
KW - Nuclease inhibitor
UR - http://www.scopus.com/inward/record.url?scp=85052810169&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2018.08.135
DO - 10.1016/j.bbrc.2018.08.135
M3 - Article
C2 - 30180947
AN - SCOPUS:85052810169
SN - 0006-291X
VL - 504
SP - 89
EP - 95
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 1
ER -